Search PDMR transactions

Notifier
Name of person with notification obligation
Kristina Torfgård
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Kristina Torfgård
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
IRLAB Therapeutics AB
Issuer´s LEI code
549300JAT34LHEI0DH60
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share IRLAB Therapeutics AB ser. A SE0012675361 Acquisition 9,000 Quantity 15.65 SEK 05/08/2024 NASDAQ STOCKHOLM AB
Share IRLAB Therapeutics AB ser. A SE0012675361 Acquisition 4,500 Quantity 15.75 SEK 05/08/2024 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
IRLAB Therapeutics AB ser. A SE0012675361 Acquisition 05/08/2024 NASDAQ STOCKHOLM AB 13,500 (Quantity) 15.68333333 SEK
Total: 13,500
<< Back